EP Patent

EP2115029B1 — Low burst poly-(lactide/glycolide) and methods to produce polymers

Assigned to Tolmar Therapeutics Inc · Expires 2015-09-16 · 11y expired

What this patent protects

Patent listed against leuprolide-mesylate.

Drugs covered by this patent

leuprolide-mesylate (LEUPROLIDE MESYLATE)

Patent Metadata

Patent number: EP2115029B1
Jurisdiction: EP
Classification: —
Expires: 2015-09-16
Drug substance claim: No
Drug product claim: No
Assignee: Tolmar Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.